期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 17, 期 8, 页码 -出版社
MDPI
DOI: 10.3390/ijms17081273
关键词
diabetes; quercetin; polyphenols; resveratrol; silymarin; kefir; probiotic; sildenafil; phosphodiesterase inhibitors; antioxidants
资金
- National Council for the Development of Science and Technology (CNPq) [303001/2015-1]
- State Foundation for Science and Technology (Fapes) [67597483]
- CNPq [307584/2015-1, 445736/2014-3, 445080/2014-0]
Because diabetes mellitus (DM) is a multifactorial metabolic disease, its prevention and treatment has been a constant challenge for basic and clinical investigators focused on translating their discoveries into clinical treatment of this complex disorder. In this review, we highlight recent experimental and clinical evidences of potential coadjuvants in the management of DM, such as polyphenols (quercetin, resveratrol and silymarin), cultured probiotic microorganisms and drugs acting through direct/indirect or pleiotropic effects on glycemic control in DM. Among several options, we highlight new promising therapeutic coadjuvants, including chemical scavengers, the probiotic kefir and the phosphodiesterase 5 inhibitors, which besides the reduction of hyperglycemia and ameliorate insulin resistance, they reduce oxidative stress and improve endothelial dysfunction in the systemic vascular circulation. In the near future, experimental studies are expected to clear the intracellular pathways involving coadjuvants. The design of clinical trials may also contribute to new strategies with coadjuvants against the harmful effects of diabetic complications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据